This is a Validated Antibody Database (VAD) review about mouse Ifnar1, based on 13 published articles (read how Labome selects the articles), using Ifnar1 antibody in all methods. It is aimed to help Labome visitors find the most suited Ifnar1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Ifnar1 synonym: Ifar; Ifnar; Ifrc; Infar; interferon alpha/beta receptor 1; IFN-R-1; IFN-alpha/beta receptor 1; IFN-alpha/betaR; INF-a receptor; type I interferon receptor 1

Knockout validation
BioLegend
mouse monoclonal (MAR1-5A3)
  • immunohistochemistry knockout validation; mouse; fig s1a
In order to examine IFN responses by cerebellar astrocytes during viral infection, BioLegend Ifnar1 antibody (BioLegend, 127305) was used in immunohistochemistry knockout validation on mouse samples (fig s1a). J Clin Invest (2017) ncbi
Bio X Cell
mouse monoclonal (MAR1-5A3)
  • blocking or activating experiments; mouse; ; fig 4d
Bio X Cell Ifnar1 antibody (BioXcell, BE0241) was used in blocking or activating experiments on mouse samples at (fig 4d). Cell Rep (2018) ncbi
mouse monoclonal (MAR1-5A3)
  • blocking or activating experiments; mouse; loading ...; fig 5
Bio X Cell Ifnar1 antibody (BioXcell, MAR1-5A3) was used in blocking or activating experiments on mouse samples (fig 5). EMBO J (2017) ncbi
mouse monoclonal (MAR1-5A3)
  • blocking or activating experiments; mouse; loading ...; fig 1a
Bio X Cell Ifnar1 antibody (BioXcell, MAR1-5A3) was used in blocking or activating experiments on mouse samples (fig 1a). J Virol (2016) ncbi
mouse monoclonal (MAR1-5A3)
  • blocking or activating experiments; mouse; loading ...
In order to study the impact of p21 signaling on monocyte reprogramming, Bio X Cell Ifnar1 antibody (BioXCell, MAR1-5A3) was used in blocking or activating experiments on mouse samples . J Clin Invest (2016) ncbi
mouse monoclonal (MAR1-5A3)
  • blocking or activating experiments; mouse; fig 3f
Bio X Cell Ifnar1 antibody (BioXCell, MAR1-5A3) was used in blocking or activating experiments on mouse samples (fig 3f). Nature (2016) ncbi
mouse monoclonal (MAR1-5A3)
  • blocking or activating experiments; mouse; loading ...
Bio X Cell Ifnar1 antibody (Bio X Cell, MAR1-5A3) was used in blocking or activating experiments on mouse samples . elife (2015) ncbi
BioLegend
mouse monoclonal (MAR1-5A3)
  • immunohistochemistry knockout validation; mouse; fig s1a
In order to examine IFN responses by cerebellar astrocytes during viral infection, BioLegend Ifnar1 antibody (BioLegend, 127305) was used in immunohistochemistry knockout validation on mouse samples (fig s1a). J Clin Invest (2017) ncbi
mouse monoclonal (MAR1-5A3)
  • blocking or activating experiments; mouse; fig 4
BioLegend Ifnar1 antibody (Biolegend, 127301) was used in blocking or activating experiments on mouse samples (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (MAR1-5A3)
  • flow cytometry; mouse; fig 5
BioLegend Ifnar1 antibody (Biolegend, MAR1-5A3) was used in flow cytometry on mouse samples (fig 5). J Immunol Res (2016) ncbi
mouse monoclonal (MAR1-5A3)
  • blocking or activating experiments; mouse; fig 6c
BioLegend Ifnar1 antibody (BioLegend, MAR1-5A3) was used in blocking or activating experiments on mouse samples (fig 6c). Retrovirology (2016) ncbi
mouse monoclonal (MAR1-5A3)
  • blocking or activating experiments; mouse; fig 6b
BioLegend Ifnar1 antibody (BioLegend, MAR1-5A3) was used in blocking or activating experiments on mouse samples (fig 6b). Mucosal Immunol (2016) ncbi
mouse monoclonal (MAR1-5A3)
  • flow cytometry; mouse; loading ...; fig 6a
BioLegend Ifnar1 antibody (BioLegend, MAR1-5A3) was used in flow cytometry on mouse samples (fig 6a). Arthritis Rheumatol (2016) ncbi
Invitrogen
mouse monoclonal (MAR1-5A3)
  • blocking or activating experiments; mouse
In order to examine TLR-induced cytokine production by SARM-deficient murine macrophages, Invitrogen Ifnar1 antibody (eBioscience, MAR1-5A3) was used in blocking or activating experiments on mouse samples . J Immunol (2014) ncbi
Articles Reviewed
  1. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  2. Webb L, Lundie R, Borger J, Brown S, Connor L, Cartwright A, et al. Type I interferon is required for T helper (Th) 2 induction by dendritic cells. EMBO J. 2017;36:2404-2418 pubmed publisher
  3. Daniels B, Jujjavarapu H, Durrant D, Williams J, Green R, White J, et al. Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection. J Clin Invest. 2017;127:843-856 pubmed publisher
  4. Lawler C, Tan C, Simas J, Stevenson P. Type I Interferons and NK Cells Restrict Gammaherpesvirus Lymph Node Infection. J Virol. 2016;90:9046-57 pubmed publisher
  5. Now H, Yoo J. AG490 and PF431396 Sensitive Tyrosine Kinase Control the Population Heterogeneity of Basal STAT1 Activity in Ube1l Deficient Cells. PLoS ONE. 2016;11:e0159453 pubmed publisher
  6. Rackov G, Hernandez Jimenez E, Shokri R, Carmona Rodríguez L, Manes S, Alvarez Mon M, et al. p21 mediates macrophage reprogramming through regulation of p50-p50 NF-?B and IFN-?. J Clin Invest. 2016;126:3089-103 pubmed publisher
  7. Kranz L, Diken M, Haas H, Kreiter S, Loquai C, Reuter K, et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature. 2016;534:396-401 pubmed publisher
  8. Li F, Wang Y, Lin L, Wang J, Xiao H, Li J, et al. Mast Cell-Derived Exosomes Promote Th2 Cell Differentiation via OX40L-OX40 Ligation. J Immunol Res. 2016;2016:3623898 pubmed publisher
  9. Masroori N, Merindol N, Berthoux L. The interferon-induced antiviral protein PML (TRIM19) promotes the restriction and transcriptional silencing of lentiviruses in a context-specific, isoform-specific fashion. Retrovirology. 2016;13:19 pubmed publisher
  10. Wu V, Smith A, You H, Nguyen T, Ferguson R, Taylor M, et al. Plasmacytoid dendritic cell-derived IFNα modulates Th17 differentiation during early Bordetella pertussis infection in mice. Mucosal Immunol. 2016;9:777-86 pubmed publisher
  11. Vlachou K, Mintzas K, Glymenaki M, Ioannou M, Papadaki G, Bertsias G, et al. Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation. Arthritis Rheumatol. 2016;68:449-61 pubmed publisher
  12. Welten S, Redeker A, Franken K, Oduro J, Ossendorp F, Čičin Šain L, et al. The viral context instructs the redundancy of costimulatory pathways in driving CD8(+) T cell expansion. elife. 2015;4: pubmed publisher
  13. Gürtler C, Carty M, Kearney J, Schattgen S, Ding A, Fitzgerald K, et al. SARM regulates CCL5 production in macrophages by promoting the recruitment of transcription factors and RNA polymerase II to the Ccl5 promoter. J Immunol. 2014;192:4821-32 pubmed publisher